Cognition Therapeutics Statistics
NASDAQ: CGTXHealthcareBiotechnologyUSD
0.8952-0.0414 (-4.42%)
At close: Oct 8, 4:00 PM ET · Delayed 15 min
Cognition Therapeutics by the numbers
Cognition Therapeutics has a market capitalization of $85.1 million based on 95.09M shares outstanding. With trailing EPS of $-0.17, Cognition Therapeutics is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 9.9% below its 50-day average and 20.4% below its 200-day average.
Average daily trading volume is 558.54K shares, or about $500,005 in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
CGTX valuation vs. peer median
| Metric | CGTX | Peer median | Difference |
|---|---|---|---|
| Market cap | $85.13M | $84.84M | +0% |
| Avg. volume | 558.54K | 234.33K | +138% |
Peer median across 8 companies: NRXS, TELO, CRDF, PMN, ICCC, MIST, ACRV, NMRA.
Valuation
- Market cap
- $85.13M
- EPS (TTM)
- $-0.17
- Shares outstanding
- 95.09M
Price and trading
- Previous close
- 0.9366
- Open
- 0.9483
- Day range
- 0.8945 – 0.9483
- 52-week range
- 0.55 – 2.05
- 52-week change
- -49.14%
- 50-day moving average
- 0.9939
- Beta
- —
- Volume
- 452.68K
- Average volume
- 558.54K
Dividends and events
- Annual dividend
- None
- Next earnings date
- Nov 5, 2026
Additional statistics
- Market Cap
- 85.13M
- Forward Pe
- -4.07
- Eps
- -0.17
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 2.05
- Week52 Low
- 0.55
- Avg Volume
- 558.54K
- Shares Outstanding
- 95.09M
- Ma50
- 0.99
- Ma200
- 1.12
- Earnings Date
- Nov 5, 2026
- Pct From52w High
- -56.33%
- Pct From52w Low
- 62.76%